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mRNA export from the nucleus depends on the ATPase activity of the DEAD-box protein Dbp5/DDX19.
Although Dbp5 has measurable ATPase activity alone, several regulatory factors (e.g., RNA, nucleoporin
proteins, and the endogenous small molecule InsP6) modulate catalytic activity in vitro and in vivo to facilitate
mRNA export. An analysis of the intrinsic and regulator-activated Dbp5 ATPase cycle is necessary to define
how these factors control Dbp5 and mRNA export. Here, we report a kinetic and equilibrium analysis of the
Saccharomyces cerevisiae Dbp5 ATPase cycle, including the influence of RNA on Dbp5 activity. These data
show that ATP binds Dbp5 weakly in rapid equilibrium with a binding affinity (KT ~ 4 mM) comparable to the
KM for steady-state cycling, while ADP binds an order of magnitude more tightly (KD ~ 0.4 mM). The overall
intrinsic steady-state cycling rate constant (kcat) is limited by slow, near-irreversible ATP hydrolysis and even
slower subsequent phosphate release. RNA increases kcat and rate-limiting Pi release 20-fold, although Pi
release continues to limit steady-state cycling in the presence of RNA, in conjunction with RNA binding.
Together, this work identifies RNA binding and Pi release as important biochemical transitions within the Dbp5
ATPase cycle and provides a framework for investigating the means by which Dbp5 and mRNA export is
modulated by regulatory factors.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
DEAD-box proteins (DBPs) are ATPase enzymes
central to RNA metabolism in all domains of life [1–
3]. Many DBPs function as bona fide helicases that
unwind duplex RNA, while others are involved in
RNA–protein complex remodeling [4–6] and/or RNA
folding [7,8] or serve as RNA sensors within the cell
[9,10]. DBPs accomplish this enormous diversity in
function using a highly conserved catalytic core that
couples ATP hydrolysis to nucleic acid binding and
release [3,8,11,12]. Consequently, DBPs are pre-
sumed to perform work via a common minimal
enzymatic scheme involving ATP binding, hydrolysis,Authors. Published by Elsevier Ltd. T
rg/licenses/by/4.0/).and subsequent phosphate (Pi) and ADP product
release [8,11,13,14].
The functional diversity of DBPs is thought to stem in
part fromkinetic and thermodynamic adaptations of this
common ATPase cycling scheme [8]. For example,
DbpA and Mss116 share a common RNA-activated
ATPase cycle pathway, but variations in the catalytic
cycle rate and equilibrium constants uniquely alter their
interaction with RNA, which may allow them to fulfill
specific biological functions [8,13–15]. This adaptive
behavior is analogous to the duty ratios of cytoskeleton
motor proteins and demonstrates how kinetic modula-
tion broadens the biological activities of an enzyme
family [8,16].his is an open access article under the CC BY license
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Fig. 1. Steady-state ATPase activity of Dbp5. (a) Time
courses of absorbance change at 340 nm assayed with
the NADH-coupled assay after mixing 660 nM Dbp5 with
(lower to upper curves) 0, 0.25, 0.5, 1, 2, 8, or 20 mM
ATP. The continuous lines through the data represent
the best fits to linear functions, yielding the steady-state
ATPase rates from the slopes. Broken lines represent
kinetic simulations of Scheme 1 and the corresponding
rate and equilibrium constants obtained from global
fitting with KinTek Explorer in Table 2. (b) [ATP]
dependence of the Dbp5 steady-state ATPase rate.
The continuous line through the data represents the best
fit to a rectangular hyperbola, yielding the maximum
velocity per enzyme (kcat) from the amplitude and the
KM,ATP from the [ATP] at half-maximum velocity
(Table 1). Uncertainty bars represent standard errors in
the fits and are within the data points.
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additionally regulated through ancillary domains that
mediate interactions with regulatory factors that can
include RNAs and/or proteins. For example, Dbp5 is
a DBP required for nuclear mRNA export that is
stimulated by RNA and further regulated by two
nucleoporins (Gle1 and Nup159) and an endoge-
nous small molecule (inositol hexakisphosphate or
InsP6) [17–28]. While it is clear that all components
have global in vitro and in vivo effects on Dbp5
activity, there is not yet a consensus on the individual
and concerted effects of these factors at a mecha-
nistic level. Critical to deciphering the effect of
regulators on the ATPase cycle of Dbp5, or any
DBP, is a quantitative characterization of the intrinsic
ATPase cycle, as it is only with this base knowledge
that we can undertake future in-depth studies on the
mechanism of regulation by trans-activating factors
and apply this to understand the in vivo cellular
function of DBPs. Deducing how trans-activating
factors modulate the ATPase cycle of individual
DBPs and the functions that emerge from this
regulation will also further our understanding of this
important class of enzymes as a whole, which
functions in almost all aspects of RNA biology.
Here, we have determined the minimal ATPase
cycle and calculated the rate and equilibrium
constants of individual biochemical transitions for
Dbp5. This work has identified slow ATP hydrolysis
and even slower subsequent phosphate release as
key bottlenecks in the ATPase cycle of Dbp5 that
function as targets for modulation by RNA and other
regulatory cofactors. We also show that the
fluorescent nucleotides N-methylanthraniloyl ATP
and ADP (mantATP and mantADP, respectively),
common tools for kinetic studies of ATPases [29–
33], significantly alter the ATPase cycle rate and
equilibrium constants of Dbp5 (Supplementary
Information). Although mant-labeled nucleotides
have been found to alter the catalytic cycles of
other molecular motors, to our knowledge, this is
the first example of such significant mant fluor-
ophore-induced alterations in DBP behavior, and
this highlights the ongoing need for system-specific
controls regarding fluorescent labels [33–36].
Having defined the minimal catalytic ATPase
cycle of Dbp5, we show that, in the presence of
RNA, phosphate release remains a limiting step in
the hydrolysis cycle of Dbp5. However, we also
observe evidence of a new RNA-binding-asso-
ciated rate-limiting step in the kinetic scheme of
Dbp5, which identifies an additional feature in the
minimal kinetic scheme of RNA-stimulated ATPase
activity. Overall, by understanding the steps that
limit Dbp5 function in various biochemical states
(e.g., RNA-bound versus free), we are building a
framework for understanding Dbp5 functions in
vivo, which may vary and be dependent upon
different regulators given the assorted functionsDbp5 has been proposed to perform [17–20,37–
42].Results
Intrinsic ATPase activity of Dbp5
Steady-state ATPase measurements
Dbp5 has intrinsic ATPase activity in the absence
of RNA or other regulatory factors [18,20,22]. As an
essential starting point for quantitative analysis
of the ATPase cycle of Dbp5, we first determined
the maximal per-enzyme cycling rate, or kcat (in
units of s−1). Under our experimental conditions
using both the NADH-coupled assay to detect ADP
product formation and PiBiP to detect phosphate
494 Pi Release Limits ATPase Cycles of Dbp5product accumulation [43,44], kcat is 0.04–0.08 s
−1 in
the presence of saturating ATP (Fig. 1 and
Table 1). The KM for ATP substrate (KM,ATP) is
1.3–1.9 mM (Fig. 1 and Table 1). These values are
comparable to published values obtained under
different solution conditions [22,45].Table 1. Rate and equilibrium constants of the Dbp5
ATPase cycle
Parameter Value Units Assay
Steady-state ATPase
kcat 0.043 (±0.001) s
−1 NADH-linked assay
0.084 (±0.002) s−1 PiBiP
KM,ATP 1.7 (±0.2) mM NADH-linked assay
1.3 (±0.1) mM PiBiP
Steady-state ATPase of ATPγS
kcat 0.036 (±0.001) s
−1 NADH-linked assay
KM,ATPγS 0.98 (±0.06) mM NADH-linked assay
ATP and mantATP binding
k+mT1 1.63 (±0.04) μM
−1
s−1
mantATP
k−mT1 11.9 (±0.7) s
−1 mantATP
KmT1 7.3 (±0.4) μM k−/k+
k+mT2 0.4 (±0.6) s
−1 mantATP
k−mT2 1.9 (±0.4) s
−1 mantATP
KmT2 5 (±7) k−/k+
kmT3,obs 0.01 (±1 × 10
−4) s−1 mantATP
KmT,overall 1 (±0.3) μM Total fluorescence
amplitude
KT 6.4 (±0.7) mM mantATP
competition
3.0 (±0.4) mM mantADP
competition
4 (±2) mM PiBiP
ATP hydrolysis
k+H 2.2 (±0.4) s
−1 PiBiP
k−H 2 × 10
−4 (±5 × 10−5) s−1 PiBiP and isotope
exchange
KH 1 x 10
−4 (±3 × 10−5) k−/k+
Phosphate release
k−Pi 0.02 (±0.1) s
−1 PiBiP
k+Pi b2 × 10
−6 μM−1
s−1
k−Pi/KPi
KPi 10 mM Steady-state Pi
inhibition
ADP and mantADP binding
KmD0 102 (±21) μM mantADP
k+mD1 98 (±15) s
−1 mantADP
k−mD1 0.2 (±0.5) s
−1 mantADP
2.611 (±0.003) s−1 Irreversible
mantADP
dissociation
KmD1 0.002 (±0.005) k−/k+ mantADP
kmD2,obs ~0.7 (±0.1) s
−1 mantADP
KD 0.36 (±0.05) mM mantADP
competition
RNA-stimulated steady-state ATPase activity
kcat 0.92 (±0.08) s
−1 NADH-linked assay
KM,RNA 3.4 (±0.8) mM NADH-linked assay
Oxygen isotope exchange
Pc 0.0416 (±0.0025) GCMSTransient kinetic analysis of the Dbp5 ATPase cycle
To define the rate-limiting steps within the intrinsic
Dbp5 ATPase cycle, we used a combination of
kinetic assays to measure individual rate and
equilibrium constants. As described below, binding
and dissociation of unlabeled nucleotides (ATP and
ADP) were measured by competition with mant-la-
beled nucleotides, and constants related to ATP
hydrolysis and product release were measured with
PiBiP and oxygen isotope exchange assays.Dbp5 nucleotide binding and dissociation. The Förster
resonance energy transfer (FRET)-based fluores-
cence enhancement associated with mant-labeled
nucleotide binding has been successfully used as a
spectroscopic probe to characterize the ATPase
cycles of DNA [33,35,46–49] and RNA helicases
[13,14,30], myosin [50–54], and kinesin [32,34,55,56]
motor proteins, as well as G-proteins [57–59], with
modest perturbations introduced by the mant moiety.
We monitored mant-labeled ATP and ADP binding to
Dbp5 from changes in FRET between Dbp5 trypto-
phans and the mant fluorophore. Time courses of
fluorescence enhancement after rapidly mixing man-
tATP with Dbp5 were described by a sum of three
exponentials (Fig. 2a and b and Supplementary
Information), while mantADP binding was described
by a sum of two exponentials (Fig. 2c and d and
Supplementary Information). The multi-exponential
behavior did not arise from the mixed mant isomers
(Supplementary Information) and was therefore mod-
eled as two (mantADP) or three (mantATP) detectable
and sequential biochemical transitions. In the case of
mantATP, the [mantATP] dependence of the three
observed rate constants yields both forward and
reverse rate constants (k+mTi and k−mTi, i = 1, 2, 3;
Table 1 and Supplementary Information). The man-
tATP binding affinity (KmT; the mantATP equivalent of
KT in Scheme 1, see Materials and Methods) deter-
mined from the ratio of k−mT1/k+mT1 is 7 μM (Table 1).
The overall mantATP binding affinity (KmT,overall, a
composite representing mantATP binding and suc-
cessively populated transitions) is in the range 1 μM
(Table 1), several orders of magnitude tighter than
the KM of unlabeled ATP (KM,ATP = 1.3–1.7 mM;
Table 1) or the ATP binding affinity (1–2 mM)
determined by NMR [45] and this study (discussed
below). The N240-fold difference between mantATP
and ATP binding affinities suggests that the mant
fluorophore affects nucleotide binding to Dbp5 [33,35].
To identify the molecular origins of potential perturba-
tions introduced by themantmoiety, we determined the
structure of Dbp5 with bound mant nucleotide.RNA/mantADP·BeF3-bound Dbp5 is structurally simi-
lar to RNA/ADP·BeF3-bound Dbp5. The structure of
Dbp5 with bound nucleotide has not been determined
Fig. 2. Mant-Nucleotide binding to Dbp5. (a) Time courses of fluorescence change after mixing 0.5 μMDbp5 with (lower
to upper) 0, 2.5, 5, 10, 20, 30, or 50 μM mantATP. The smooth lines through the data represent the best fits to three
exponentials. (b) Full time courses from (a) shown on a log scale to 200 s. (c) [mantATP] dependence of the observed rate
constants associated with mantATP binding. Continuous lines represent the best linear fits to the data. Uncertainty bars
representing the standard errors of the best fits are within the data points. (d–f) Analogous mantADP binding data fitted to
two exponentials shown on linear (d) and log (e) scales and with rate constants fitted to hyperbolic or linear functions (f).
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bound to RNA and the ATP analog (ADP·BeF3) has
been reported [27]. Therefore, we determined the
structure of Dbp5 with bound mantADP·BeF3 and
RNA to assess the influence of the mant moiety and to
identify any structural perturbations in the complex.
The crystal structure of RNA/mantADP·BeF3-bound
Dbp5, refined to a resolution of 1.8 Å, reveals hydro-
phobic interactions between themantmoiety and three
adjacent residues (Met110, Phe112, and Val181;
Fig. 3a). Binding of mantADP buries 3397 Å2 of the
solvent-accessible surface area of Dbp5, with the
mant moiety of the ligand accounting for 511 Å2. If
we assume that such change in hydrophobic
surface area provides −15 ± 1.2 cal mol−1 Å−2
[60], the additional contacts made by the mantfluorophore could potentially provide a total of −
7.6 kcal mol−1 to the binding free energy. The mant
moiety would therefore increase the ATP affinity
from 6.4 mM (ΔG0′ = −3.0 kcal mol−1) to 20 nM
(ΔG0′ = −10.6 kcal mol−1) and the ADP affinity
from 360 μM (ΔG0′ = −4.8 kcal mol−1) to 1 nM
(ΔG 0 ′ = − 12.4 kcal mol − 1 ). Although these
mant-nucleotide binding constants are considerably
tighter than observed (Table 1), it demonstrates that
hydrophobic interactions with the mant moiety can
account for the tighter binding affinity.
Superposition of RNA/mantADP·BeF3-bound
Dbp5 onto RNA/ADP·BeF3-bound Dbp5 (PDB ID
3PEY) reveals a similar overall structure of the
ATPase and bound ligands (rmsdCα = 0.1106 and
rmsdall-atom = 0.3939) [27], suggesting that structural
Fig. 3. Interactions between mant-ADP·BeF3 and Dbp5. (a) The mant fluorophore buries adjacent residues (Val181,
M110, and Phe112) of Δ90Dbp5 via hydrophobic interactions (b4.0 Å). The mant moiety hydrogen bonds (broken lines)
with waters at the solvent-exposed surface. (b) Displacement of a network of hydrogen-bonded water molecules by the
mant fluorophore. Δ90Dbp5-ADP·BeF3 (blue) and the associated water molecules (red) of 3PEY superimposed to
Δ90Dbp5-mant-ADP·BeF3 and the associated water molecules (gray). π Stacking of the adenine is maintained. rmsd =
0.1106 Å.
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mant moiety are minimal (Figs. S4 and S5). One
notable difference between the superimposed struc-
tures is the displacement of a set of eight water
molecules found in the nucleotide-binding site of the
ADP·BeF3-bound structure by the mant moiety
(Fig. 3b), which may further contribute to the
differences in mant-nucleotide binding.Fig. 4. Unlabeled nucleotide binding affinity measured
by competition with mant nucleotides. (a) Time courses of
fluorescence change after mixing 0.5 μMDbp5 with 50 μM
mantADP and 0, 0.175, 0.75, 2, 5, or 10 mM ADP (upper to
lower). Continuous lines through the data represent best
fits to two exponentials. (b) [nucleotide] Dependence of the
fastest observed rate constant (k1,obs) after mixing 0.5 μM
Dbp5 with a solution of 50 μM mantADP supplemented
with 0, 0.1, 0.3, 0.6, 1, 2.5, 5, or 11 mMATP (black squares).
Black circles represent the fastest observed rate constant of
mantADP binding on mixing 0.5 μM Dbp5 with a solution of
50 μM mantADP supplemented with 0.005, 0.015, 0.03,
0.0625, 0.175, 0.75, 2, 5, or 10 mM ADP. Continuous lines
represent best fits to Eq. (13).Unlabeled nucleotide binding to Dbp5. Kinetic com-
petition between mantATP or mantADP and unla-
beled ATP was performed to obtain parameters for
unlabeled ATP binding and dissociation. ATP slows
all observed rate constants associated with mantATP
and mantADP binding (Fig. 4 and Table 1), consistent
with ATP binding in a rapid equilibrium (N300 s−1)
and competing with mant nucleotides for Dbp5
binding [51,61]. Rapid ATP binding kinetics are
beyond stopped-flow detection limits (~2 ms); thus,
we used the reduction in kmT1,obs with increasing
[ATP] to estimate an unlabeled ATP binding affinity
(KT) of 6 mM [Fig. 4b, Eq. (13), and Table 1].
Competition with mantADP yields an ATP affinity of
3 mM (Fig. 4 and Table 1). The comparable (i.e., b
2-fold difference) ATP binding affinities determined
from competition with mantATP or mantADP sug-
gests that mantATP turnover (i.e., hydrolysis,
product release, and any steady-state ATPase
activity) occurs muchmore slowly than initial binding
of ATP and does not affect the measured KT (see
Supplementary Information).
Kinetic competition between mantADP and ADP
demonstrates that Dbp5 bindsADP in rapid equilibrium
but ~10-fold more tightly than ATP (KD = 360 μM;
Table 1 andFig. 4), in agreementwith published values
(400–570 μM) [45]. Thus, mant-labeled nucleotides
497Pi Release Limits ATPase Cycles of Dbp5bind Dbp5 more tightly than their unlabeled counter-
parts (Table 1). The multiple observed phases in
mant-nucleotide binding, particularly those of man-
tADP binding, may reflect isomerization steps facilitat-
ed by additional interactions between Dbp5 and the
fluorophore. These isomerizations may also contribute
to high-affinity binding of mant-labeled nucleotides.Dbp5 ATP hydrolysis and phosphate release. Fluo-
rescently labeled phosphate binding protein (PiBiP)
has been used to measure transient Pi release from
DBPs and other molecular motor proteins
[13,14,44,53]. Its tight binding of Pi (Kd = 0.1 μM)
and rapid association rate constant (N3 × 108 M−
1 s−1) provides real-time fluorescent detection of
transient and steady-state Pi release [62]. Time
courses of PiBiP fluorescence enhancement after
rapidly mixing Dbp5 with ATP display multiple
phases. The most prominent features are a lag
followed by a linear phase (Fig. 5). The linear portion
corresponds to steady-state ATPase cycling. The
steady-state cycling parameters (kcat = 0.08 s
−1 andFig. 5. Transient and steady-state Pi release during
Dbp5 ATPase cycling. (a) Time courses of fluorescence
change after mixing 0.5 μM Dbp5 with 5 μM PiBiP
containing (lower to upper curves) 0, 0.5, 1, 2, or 5 mM
ATP. Fits to Eq. (14) are shown as broken lines through the
data. Simulated data (using rate and equilibrium constants
obtained from KinTek Explorer global fitting; Table 2) are
shown as dotted lines through the data. (b) [ATP]
dependence of the observed Pi release lag phase rate
constant (λ). Continuous line through the data points
represents best fit to a rectangular hyperbola [Eq. (15)].KM,ATP = 1.3 mM) obtained from fitting the [ATP]
dependence of the turnover rate (i.e., the slope of the
linear regime) toEq. (10) agreewell with thoseobtained
with the NADH-coupled assay (Table 1), providing
independent determination of the steady-state
parameters (Table 1).
The lag phase is defined by an observed rate
constant whose value depends hyperbolically on the
[ATP], yielding an ATP binding affinity (KT) of 4 mM
[Fig. 5 and Eq. (15)], comparable to the values
obtained by competition with mantATP and man-
tADP (Fig. 4). The observed lag phase rate constant
at saturating ATP (λ∞) has a value of 2 s
−1 and
corresponds to the sum of the ATP hydrolysis and Pi
release rate constants (Scheme 1) as follows[13,14]:
λ∞ ¼ kþH þ k−H þ k−Pi ð1Þ
The intercept of the lag phase at zero ATP (λ0) is
defined by:
λ0 ¼ k−T k−H þ k−T k−Pi þ kþHk−Pik−T
¼ k−H þ k−Pi þ
kþHk−Pi
k−T
ð2Þ
and has a value of ~0.02 s−1, though this is subject
to experimental uncertainty since it is close to the
origin. When ATP dissociation is rapid (k−T ≫ other
rate constants preceding ADP release in Scheme 1,
a condition that is fulfilled since ATP binds in rapid
equilibrium), the net contributions from the third term
(k+Hk−Pi/k−T) of Eq. (2) are negligible and λ0
simplifies to the sum of ATP resynthesis (k−H) and
Pi release (k−Pi) rate constants:
λ0∼k−H þ k−Pi ð3Þ
Combining Eqs. (1) and (3) allows the observed
lag phase rate constant to be expressed as:
λ∞∼kþH þ λ0 ð4Þ
Given the values of λ∞ (~2 s
−1) and λ0 (~0.02 s
−1),
we conclude that ATP hydrolysis (k+H) dominates λ∞
and occurs with a rate constant of ~2 s−1 (Table 1).
This and a steady-state cycling kcat of 0.08 s
−1
indicate that ATP hydrolysis is not rate limiting, though
it can contribute to the value of kcat[13–15].Oxygen isotope exchange.Oxygen isotopic exchange
experiments were performed to determine the ratio
between reverse hydrolysis (k−H) and phosphate
release (k−Pi). After hydrolysis, Dbp5 with bound
ADP-Pi will either release Pi or resynthesize ATP,
depending on the relative rate constants for Pi
release and reverse hydrolysis. In each ATP hy-
drolysis event, a water-derived oxygen is incorpo-
rated into the liberated Pi and there is a defined
probability (depending on the solution enrichment
Table 2. Rate and equilibrium constants determined from
global fitting
Parameter Value Units Assay
Steady-state ATPase activity
kcat 0.04 (±0.0001) s
−1 Eq. (8)
KM,ATP 1.4 (±1.1) mM Eq. (9)
ATP binding
k+T 0.92 (±0.03) μM
−1 s−1 KinTek steady-state
simulation
k−T 3670 s
−1 KinTek steady-state
simulation
KT 4 mM Constrained from
competition assay
ATP hydrolysis
k+H 0.16 (±5 × 10
−4) s−1 KinTek steady-state
simulation
0.72 (±0.01) s−1 KinTek PiBiP
simulation
k−H 6 × 10
−4 (±8 × 10−7) s−1 KinTek steady-state
simulation
0.38 (±0.05) s−1 KinTek PiBiP
simulation
KH 0.004 (±5 × 10
−4) KinTek steady-state
simulation
0.53 (±0.07) KinTek PiBiP
simulation
Phosphate release
k−Pi 0.062 (constrained) s
−1 KinTek steady-state
simulation
0.04 (±0.02) s−1 KinTek PiBiP
simulation
k+Pi b1 × 10
−6
(constrained)
s−1 KinTek steady-state
simulation
b1 × 10−6 s−1 KinTek PiBiP
simulation
KPi N1 × 10
−4 μM KinTek steady-state
simulation
N1 × 10−4 μM KinTek PiBiP
simulation
ADP release
k+D 0.2 μM
−1 s−1 KinTek steady-state
simulation
k−D 64 (±16) s
−1 KinTek steady-state
simulation
KD 0.31 mM Constrained from
competition assay
498 Pi Release Limits ATPase Cycles of Dbp5of 18O) that the water-derived oxygen is a heavy
isotope. Therefore, the 18O isotope content in the
released Pi product reveals the number of hydroly-
sis events that occurred before Pi release and
determine the probability ratio of ATP resynthesis
versus phosphate release [13,15,61,63]. In the
absence of significant reverse hydrolysis, Pi will
have a single water-derived oxygen, but significant
reverse hydrolysis will generate Pi with multiple
water-derived oxygens due to multiple rounds of
hydrolysis and resynthesis prior to Pi release.
The Pc value is determined by measuring the
relative populations of singly and multiply labeled
18O phosphates and is defined by the ATP resynthe-sis and Pi release constants according to the
following[61,63,64]:
Pc ¼ k−Hk−H þ k−Pi
ð5Þ
The ratio of the 18O2:
18O1 species was 0.0101 ±
0.0009 for hydrolysis by Dbp5 in 48.5% 18O water
(see Materials and Methods for full description of
data analysis). This ratio corresponds to a Pc value
of 0.0113 ± 0.0026, indicating that Pi release occurs
almost 100-fold faster than reverse hydrolysis (k−Pi/
k−H = 99) and little ATP resynthesis occurs during
steady-state cycling. Consequently, the y-intercept of
the lag phase rate constant λ0[Eq. (2)] is dominated by
k−Pi with a value of ~0.02 s
−1 and a k−H value of
0.0002 s−1[Eq. (3) and Table 1]. Thus, Dbp5 hydro-
lysis is essentially irreversible despite slow Pi release.
The determined value of the phosphate release
rate constant of k−Pi ~ 0.02 s
−1 is comparable to
the steady-state cycling rate, suggesting that it or a
transition preceding rapid Pi release limits Dbp5
cycling.Pi rebinding during ATPase cycling. To assess if Pi
rebinding contributes to overall Dbp5 ATPase
cycling and to estimate the Pi rebinding rate
constant, we used the NADH assay (Pi release is
irreversible in the PiBiP assay due to PiBiP and mop)
to measure Dbp5 steady-state ATPase activity over
a wide range of added free Pi. The Dbp5 ATPase
activity is not affected by inclusion of Pi up to 10 mM,
yielding an apparent K Pi;SS ¼ ½Pi½HD½HDPi value N10 mM
during steady-state cycling and making Pi release
essentially irreversible.
Although the steady-state distributions of the bio-
chemical states are not identical with the equilibrium
distributions, it is possible to relate this apparent KPi,SS
to the true equilibrium constant (K Pi;eq ¼
k−Pi
kþPi
) with
consideration of reaction flux. During initial steady-state
cycling, the reaction flux at every transition (Scheme 1)
is constant and equal to the observed product release
rate, v0[Eq. (10)]. For Pi release and rebinding, this is
given by the expression
k−Pi HDPi½ −kþPi Pi½  HD½  ¼ v0≤ H½ Tkcat ð6Þ
Dividing both sides of Eq. (6) by k+Pi[HDPi],
rearranging terms, and substituting in the steady-s-
tate and equilibrium definitions of KPi yields
kPi;eq ¼
k−Pi
kþPi
¼ Pi½  HD½ 
HDPi½  þ
v0
kþPi HDPi½ 
¼ K Pi;SS þ
v0
kþPi HDPi½ 
NK Pi;SS ð7Þ
indicating that the affinity of Pi at equilibrium is always
weaker than that in steady state. Therefore, since
499Pi Release Limits ATPase Cycles of Dbp5KPi,eq N 10 mM and k−Pi ~ 0.02 s
−1, k+Pi must be
slower than 2 × 10−6 s−1. These data suggest that Pi
rebinding by Dbp5 is negligible under our assay
conditions and does not result in substantial product
inhibition, even in the absence of the Pi mop.
Kinetic simulations from global fitting
Our transient kinetic analysis indicates that the
intrinsic ATPase cycle of Dbp5 features rapid, weak
ATP binding, moderately slow hydrolysis, and
rate-limiting Pi release followed by rapid ADP
dissociation. To verify the experimentally deter-
mined rate and equilibrium constants, we globally fit
ATPase time courses acquired with NADH and
PiBiP assays (Figs. 1 and 5) at different [Dbp5] and
[ATP] to Scheme 1 using KinTek Explorer software.
All the rate constants in Scheme 1 were uncon-
strained in global fitting with the exception of the
following ratios: the ATP and ADP binding affinities
(defined by the ratio of k−/k+) were constrained to the
experimentally determined values of 6 mM and
310 μM, respectively, and Pi release was constrained
to a value ~100-fold faster than reverse hydrolysis.
Our only fully constrained rate constant was Pi
rebinding, which was set at a near-zero value since
Pi release from Dbp5 is essentially irreversible during
steady-state cycling (and is irreversible in the presence
of PiBiP). The fundamental rate constants obtained
from global fitting (Table 2) agree well with the
experimentally determined rate constants (Table 1)
and account for the experimental time courses for
various assays.
Global fits by KinTek Explorer closely match the
experimental NADH assay data (Fig. 1) when Pi
release is either partially or solely rate limiting. The
requirement for two partially rate-limiting steps (from
the distinguishing lag phase in transient phosphate
release assays; Fig. 5) eliminates scenarios in which
hydrolysis does not also contribute to kcat. In support
of this scheme, simulations generated from global
fitting outputs are very sensitive to changes in both
ATP hydrolysis/resynthesis and Pi release but are
insensitive to changes in ATP/ADP binding and
dissociation provided that those steps are much
faster than hydrolysis and Pi release. The best
global fit of the NADH experimental data was
achieved with ATP hydrolysis (k+H) at 0.16 s
−1,
ATP resynthesis (k−H) at 6 × 10
−5 s−1, and Pi
release (k−Pi) at 0.06 s
−1 with minimal phosphate
rebinding (k+Pi ~ 0), thereby making Pi release the
major determinant of kcat (Table 2).
We also globally fitted transient Pi release data
(Fig. 5) with thermodynamically constrained rapid
ATP/ADP binding and dissociation and a Pc value of
0.01. Independent of the steady-state NADH assay
global fits by KinTek Explorer, the transient Pi release
time courses are best globally fitted by a mechanism
in which Pi release is the major determinant of kcat:ATP hydrolysis (k+H) occurs at 0.62 s
−1, ATP resyn-
thesis (k−H) occurs at 0.001 s
−1, and Pi release (k−Pi)
occurs at 0.1 s−1.ConstrainingATPhydrolysis (k+H) to
0.16 s−1 (the best global fit output from the NADH
assay data) yields simulation outputs that overlay with
the PiBiP data (Table 2 and Fig. 5). Once again, in all
converged parameters, Pi release limits the kcat of
Dbp5.
The steady-state cycling parameters kcat and
KM,ATP can also be calculated from fundamental
rate constants, but the relationship depends on the
kinetic scheme. Using a minimal four-state model
(Scheme 1), making no assumptions about the speed
or reversibility of any of the associated transitions, the
theoretical kcat andKM,ATP values are given by[13,65]:
kcat ¼ kþHk−Pi k−DkþH þ k−Hð Þ kþPi þ k−Dð Þ þ kþHk−Pi þ k−Pi k−D
ð8Þ
KM;ATP ¼ k−T k−H kþPi þ k−Dð Þ þ kþPik−Dð Þ þ kþHk−Pik−DkþT kþH þ k−Hð Þ kþPi þ k−Dð Þ þ kþHk−Pi þ k−Pik−Dð Þ
ð9Þ
Substituting the rate constants derived from global
fitting of either steady-state NADH or PiBiP assays
(Table 2) into the abovementioned equations yields
a kcat of 0.04 s
−1 and a KM,ATP of 1.1 mM, which
closely match our experimental steady-state data
(0.04–0.08 s−1 and 1.3–1.5 mM, respectively;
Table 1).
In summary, the rate constants determined from
globally fitting our experimental data to Scheme 1
(Table 2) are consistent with those determined
experimentally (Table 1). Moreover, the global
enzyme cycling parameters, kcat and KM, calculated
using individual rate constants obtained from global
fitting are comparable to the values determined
experimentally. The high degree of agreement
between experimentally derived parameters (both
steady-state ATPase and transient kinetics) and
global fitting outputs demonstrates the robustness of
the proposed kinetic scheme and the experimentally
determined parameters. As such, the minimal
ATPase scheme used here to model Dbp5 activity is
sufficient to account for all observed transitions, and it
serves as a quantitative framework for evaluating the
influence of RNA and regulatory factors.
Alteration of the intrinsic Dbp5 ATPase cycle
by RNA
Pi release in the presence of RNA
RNA significantly impacts the Dbp5 ATPase cycle
[22]. To quantify these changes within the framework
described thus far, we performed steady-state
Fig. 7. Steady-state distribution of Dbp5 ATPase cycle
intermediates. In vitro conditions are 20 mM ATP, 0 mM
ADP, and 0 mM Pi. In vivo conditions are 2.1 mM ATP
[72], 470 μM ADP [72], 2.5 mM Pi[73].
500 Pi Release Limits ATPase Cycles of Dbp5ATPase assays with Dbp5 in the presence of
saturating levels of ATP (20 mM) and varying [RNA]
(up to 7 mM), which resulted in an ~20-fold acceler-
ation of kcat (0.92 ± 0.08 s
−1), confirming earlier
studies (Fig. 6 and Table 1) [22]. Given that intrinsic
Dbp5 ATPase cycling is mainly limited by Pi release,
RNA must minimally accelerate Pi release 20-fold to
achieve this increase in kcat. We therefore evaluated if
RNA had the predicted effect on Pi release and also
whether or not our modeled rate constants from
Scheme 1 were predictive of overall intrinsic Dbp5
steady-state cycling.
Pi release is primarily rate limiting in the absence
of RNA and other cofactors. Therefore, the majority
of Dbp5 populates the ADP-Pi state under in vitro
steady-state cycling conditions (Fig. 7). We took
advantage of this Dbp5-ADP-Pi accumulation in a
series of dual-mixing experiments to test the effects of
RNA on Pi release from the pre-formed Dbp5-ADP-Pi
state. Dbp5 was first rapidly mixed with ATP andFig. 6. RNA-stimulated steady-state ATPase activity of
Dbp5. Time courses of absorbance change at 340 nm
assayed with the NADH-coupled assay after mixing
100 nM Dbp5 and 20 mM ATP with (lower to upper
curves) 0, 0.45, 1.25, 2, 3, or 4.5 mM polyuridylic acid
(concentration refers to total nucleotides). The continuous
lines through the data represent the best fits to linear
functions, yielding the steady-state ATPase rates from the
slopes. (b) [ATP] dependence of the RNA-stimulated Dbp5
steady-state ATPase rate. The continuous line through the
data represents the best fit to Eq. (11), yielding the
maximum velocity per enzyme (kcat) from the amplitude
and the KM,RNA from the [ATP] at half-maximum velocity
(Table 1). Uncertainty bars represent standard errors in the
fits and are within the data points.“aged” for various times to allow biochemical interme-
diates along the ATPase cycle to form, then rapidly
mixed again with a range of [RNA] while monitoring Pi
release with PiBiP. Based on the intrinsic rates
determined above, delay times of 0.05 s, 6 s, and
25 s should result in progressive Dbp5 population
of ATP-bound (pre-hydrolysis), ADP-Pi -bound
(post-hydrolysis), and ADP-bound (post Pi release)
states, respectively.
Delay times ≥6 s abolished the lag phase in PiBiP
fluorescence time courses with Dbp5 alone (i.e., no
RNA; Fig. 8a). This observation is consistent with
formation of the post-hydrolysis ADP-Pi state during
aging, thereby bypassing (at least) one of the
transitions contributing to the lag phase observed
in single-mixing experiments (Fig. 5). Furthermore, a
rapid burst of PiBiP fluorescence was observed with
longer delay times (25 s; Fig. 8a), consistent with
PiBiP binding to Pi liberated by Dbp5 via hydrolysis
events that occurred during aging. From these data,
we can conclude that our modeled rate constants for
intrinsic Dbp5 cycling are predictive of actual Dbp5
behavior and that these dual-mixing experiments
can be used to interrogate the effect of RNA on Pi
release.
Upon addition of RNA in the second mix after
aging, time courses of PiBiP fluorescence display a
lag phase followed by a linear phase (Fig. 8b),
independent of the age time (from 0 to 25 s) even if
the lag is absent from time courses with Dbp5 alone
(e.g., 6 s age time). The lag phase observed rate
constant with 10 mM RNA is ~4–6 s−1 for all aging
periods examined. The lag phase observed rate
constant also depends hyperbolically on [RNA],
reaching a maximum value of ~5.5 (±2) s−1 at
saturating [RNA] (Fig. 8c). Thus, RNA alters the
hydrolysis cycle of Dbp5 by introducing two or more
new rate-limiting steps, at least one of which does
not depend on pre-population of a particular
Dbp5-nucleotide-bound state. This is most likely
an RNA-binding-dependent transition—either slow
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binding—which must occur prior to establishing a
new steady state.
The [RNA] dependence of the lag (Fig. 8c) is
presumably related to the RNA affinity (Kd,RNA) of
Dbp5 (with bound nucleotide) at sub-saturatingFig. 8. Transient RNA-stimulated Pi release during
Dbp5 ATPase cycling. (a) Time courses of fluorescence
change after mixing 5 μM Dbp5 with 4 mM ATP and aging
for (lower to upper) 0.05, 6, or 25 s prior to rapidly mixing
with 5 μM PiBiP. Broken lines are best fits to (lower to
upper) Eq. (14), linear equation, or bimolecular binding
plus a linear phase, respectively. (b) Time courses of
fluorescence change after mixing 5 μM Dbp5 with 4 mM
ATP, aging for 6 s, and then rapidly mixing with 0 or 10 mM
RNA in the presence of 5 μM PiBiP. Fits to Eq. (16) are
shown as broken lines through the data. (c) [RNA]
dependence of the observed Pi release lag phase rate
constant (λ) where pre-equilibrated Dbp5 and RNA are
rapidly mixed with ATP and PiBiP. Continuous line through
the data points represents best fit to a rectangular
hyperbola [Eq. (15)], yielding a maximum observed rate
constant of 5.5 ± 2 s−1 upon extrapolation of the fit to
saturating RNA. The [RNA] at half maximal is ~3 mM
under these nonsaturating ATP concentrations.[ATP], and its value of 3 (±3) mM agrees well with
the Michaelis constant KM,RNA[14] of 3.4 (±0.8) mM
for [RNA]-dependent Dbp5 ATPase obtained from
steady-state NADH assays (Fig. 6b and Table 1).
The lack of a Pi burst from the pre-formed
Dbp5-ADP-Pi state following RNA binding (delay
times ≥6 s; Fig. 8b) also establishes that Pi release
must continue to be slow and partially rate limiting,
even when RNA is present. However, we note that
the dual-mixing experiments do not rule out the
possibility that hydrolysis may also limit kcat in the
presence of RNA. We therefore conclude that at
least two biochemical transitions—an isomerization
associated with RNA binding and Pi release—limit
RNA-activated Dbp5 ATPase cycling.Oxygen isotope exchange in the presence of RNA
RNA may also promote ATP hydrolysis by Dbp5,
as with other DBPs [8,66,67]. A faster observed
hydrolysis rate constant could result from accelerat-
ed ATP resynthesis, ATP hydrolysis, or both. The
very slow rate of ATP resynthesis in the intrinsic
Dbp5 ATPase cycle makes the first option a distinct
possibility, and this is crucial to understanding the
potential effects of other regulators. We therefore
performed oxygen isotope exchange analysis of the
RNA-activated, steady-state Dbp5 ATPase.
The Pc value in the presence of RNA is 0.042 ±
0.003 (versus 0.01 in the absence of RNA), which
equates to a Pi release rate constant that is ~25-fold
faster than ATP resynthesis (Table 1). Because Pi
release is accelerated 20-fold in the presence of
RNA, ATP resynthesis must also be accelerated to
maintain the observed 4-fold difference in Pc value.
Using the rate constants for Pi release, the Pcvalues,
and Eq. (5), we estimate that RNA accelerates ATP
resynthesis by Dbp5 ~80-fold. Accelerating ATP
resynthesis increases the observed ATP hydrolysis
rate constant (i.e., shortens ATP hydrolysis relaxa-
tion time), as it is determined by the sum of forward
and reverse rate constants [68].Discussion
General features of the intrinsic Dbp5
ATPase cycle
Dbp5 has a slow maximum turnover rate (kcat:
0.04 s−1) and a weak KM,ATP (1.3–1.9 mM). The slow
kcat results from slow ATP hydrolysis coupled to even
slower Pi release, both of which limit overall cycling,
though Pi release is the major determinant. It is
experimentally difficult to measure hydrolysis directly
by chemical quench flow [13,66,69], given weak ATP
binding to Dbp5 (i.e., saturation requires ~20 mM
ATP, a small fraction of which will be hydrolyzed even
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thin-layer chromatography, HPLC, and other conven-
tional means technically challenging). However,
isotope exchange experiments and the presence of
the lag in PiBiP fluorescence time courses provide
sufficient evidence to implicate both hydrolysis and Pi
release as slow and relatively irreversible transitions
that limit Dbp5 ATPase cycling in the absence of RNA
and other regulatory factors. Current structural and
biochemical data support a role for protein regulators
(i.e., Gle1-InsP6 and Nup159) in facilitating enzyme
recycling post-hydrolysis [25,27], which fits well with
the kinetic bottlenecks identified here. Future studies
will be required to investigate if these regulators
function in this fashion and/or facilitate other transi-
tions in the ATPase cycle that become limiting in the
presence of RNA and trans-activating factors.
Interactions with mant-labeled nucleotides
We found that mant-labeled nucleotides severely
perturb the kinetics and thermodynamics of the
Dbp5 ATPase cycle. The rate and equilibrium
constants are affected by several orders of magni-
tude and the rate-limiting transitions for intrinsic
cycling are also perturbed (Supplementary Informa-
tion). This is the first example to our knowledge of
such dramatic differences in behaviors between
native and mant-labeled nucleotides with the DBP
family of enzymes. While the origin of this fluor-
ophore effect is still unclear, additional hydrophobic
interactions with the mant fluorophore (Fig. 3 and
Supplementary Information) are likely to contribute.
It is intriguing to speculate if the ability of Dbp5 to
discriminate between ATP and ATP-like molecules
may serve some additional function in vivo, as was
recently described for the DBP Ded1 in AMP sensing
[70]. Certainly, it demonstrates that fluorophore
effects are not uniform even between closely related
enzymes and must be checked [33,35,48].
General features of the Dbp5 RNA-stimulated
ATPase cycle
Dbp5 steady-state ATPase cycling is accelerat-
ed 20-fold by RNA (Table 1). Consequently, the
main rate-limiting step in the intrinsic Dbp5
cycle—Pi release—must be accelerated by RNA
at least 20-fold. Intriguingly, RNA binding
(kHT + R = 1–5 s
−1) becomes partially rate limiting
and, together with Pi release (k−RPi = 1–5 s
−1), limits
steady-state Dbp5 ATPase cycling in the presence of
RNA. This suggests that the interaction time between
Dbp5 and RNA is ≥0.4 s ðτRNA binding þ τPi release
¼ 1kHTþR þ 1k−RPi ≥
1
5 s−1 þ 15 s−1 ¼ 0:4 sÞ, which may be
significant for the role of Dbp5 in mRNA export (see
the discussion below) and/or other cellular
processes.Comparison to other DBPs
The intrinsic Dbp5 ATPase cycle appears very
similar to that of other RNA helicases. Like Dbp5,
both DbpA and Mss116 display unfavorable hydro-
lysis and fully or partially rate-limiting Pi release in
the absence of RNA [13–15]. In the case of DbpA,
hydrolysis is so unfavorable that it is undetectable in
the absence of its RNA activator, the peptidyl-trans-
ferase center (PTC) of the 23S ribosomal RNA
[13,15,71]. Although the equilibrium constants for
ATP hydrolysis (KH) and Pi release (KPi) of intrinsic
Dbp5 ATPase activity actually favor progression
through the ATPase cycle, the slow rate constants
associated with both transitions bottleneck the
intrinsic cycle at similar positions (i.e., biochemical
states) as with DbpA and Mss116 cycling. In this
sense, Dbp5 appears to be typical of the DBP family.
Despite these similarities with other representative
DBPs, some unique features of Dbp5 should be
noted. First is the extremely weak millimolar ATP
binding affinity (~4 mM) as compared to sub-milli-
molar binding affinities for most other studied DBPs
[13,14]. As a result, little Dbp5-ATP is populated
under physiological conditions[72,73]; rather, free
Dbp5, Dbp5-ADP-Pi, and Dbp5-ADP are favored
(Fig. 7).
A second feature of the intrinsic ATPase cycle of
Dbp5 is the slow reverse hydrolysis (ATP resynthe-
sis) rate constant both in the presence and in the
absence of RNA, which maintains Dbp5 in an
ADP-Pi state when coupled with even slower Pi
release (Fig. 7). Although accelerated at least
20-fold with RNA, Pi release remains at least partially
rate limiting, such that Dbp5 significantly populates
the ADP-Pi state even in the presence of RNA.
Formation of such a stabilized biochemical interme-
diate may promote distinct and/or high-affinity
interactions with RNAs important for in vivo function,
as with other DBPs [10,13–15], which may be
required for the proposed ribonucleoprotein (RNP)
remodeling activity of Dbp5 at NPCs [74–76].
Alternatively, it has been demonstrated that Dbp5
shuttles through the nucleus [19], interacts with
transcriptional machinery [39], and travels with
nuclear RNPs from the site of transcription to
NPCs [37]. This latter activity may rely on Dbp5
acting as an ATP-dependent RNA clamp and
remaining bound to an mRNA, similar to eIFAIII as
part of the exon-junction complex[9]. Maintenance of
Dbp5 in an RNA-bound state would allow Dbp5 to be
loaded on to mRNPs in the nucleus during mRNP
biogenesis and subsequently released upon reach-
ing the cytoplasmic side of an NPC where known
regulators (i.e., Gle1 and Nup159) are located,
resulting in spatial regulation of the Dbp5 ATPase
cycle. Within such a model, completion of the
ATPase cycle upon exiting the nucleus would
facilitate directional mRNP export by initiating
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remodeling. mRNA export times are reported to be in
the range of a few hundred milliseconds [77–80], as
such the ability of Dbp5 to remain bound to RNA for
≥400 ms is consistent with a clamp model for Dbp5
in mRNA export. To distinguish among these
possibilities related to mRNA export and to under-
stand how Dbp5 functions in other cellular process-
es, it will be critical to continue to investigate how
regulators individually, and in combination, alter the
Dbp5 ATPase cycle.Materials and Methods
Chemicals
All chemical reagents were of the highest purity
commercially available. Millipore MiliQ® water (filtered
through a 0.2-μm filter) or Sigma RNase-free water was
used in all buffers. ATP (SigmaA7699, ≥99%purity assayed
by HPLC, ≤0.1% inorganic phosphate) and ADP (Roche
Molecular Biochemicals) concentrations were determined by
absorbance using ε259 of 15,400 M
−1 cm−1. Polyuridylic acid
(polyU RNA) (SC-215733A; Santa Cruz Biotechnology) was
dialyzed extensively against distilled deionized water and
ethanol precipitated prior to use. RNA concentrations were
determined by absorbance using ε260 of 9660 M
−1 cm−1 and
are in units of nucleotides. Mant-labeled nucleotides (2′ and
3′ mixed isomer, mantATP, and mantADP from Invitrogen;-
mantATP, mant-dATP, and mant-dADP from Jena Biosci-
ences) concentrations were determined by absorbance
(ε255 = 23,300 M
−1 cm−1). One molar equivalent of MgCl2
was added to all nucleotides immediately before use.
All assays were performed at 25 ± 0.1 °C in 30 mM
Hepes(pH 7.5), 100 mM KCl, 2 mM MgCl2, and 2 mM
DTT.
Protein expression, purification, and labeling
N-terminal 6×His-tagged Dbp5 was expressed and
purified from Escherichia coli as previously described
[81]. The E. coli phosphate binding protein (PiBiP) was
purified and labeled with MDCC (7-diethylamino-3-(((2--
maleimidyl)ethyl)amino)carbonyl coumarin (Thermo Fish-
er Scientific Inc.) as previously described [44,82].
Protein crystallization
Dbp5 crystal structures used the construct Δ90Dbp5
(Dbp5 residues 91–482) instead of full-length Dbp5 [27],
purified as described above. In preparation for crystalliza-
tion, Δ90Dbp5 was dialyzed into 30 mM Hepes(pH 7.5),
400 mM NaCl, 1 mM DTT, and 0.25 mM InsP6 in 10%
glycerol as previously described [27]. The N-terminal
6×His tag was cleaved overnight at 4 °C with tobacco
etch virus (TEV) protease in 5 mMDTT. Cleaved Δ90Dbp5
was purified by nickel affinity chromatography with
Ni2+-NTA agarose (Qiagen) followed by size-exclusion
chromatography over a Superdex 200 (10/300) GL column
(GE Healthcare) in 10 mM Hepes(pH 7.5), 100 mM NaCl,1 mM DTT, and 0.25 mM InsP6 in 10% glycerol. Purified
Δ90Dbp5 was concentrated after the addition of 5 mM
MgCl2. The Δ90Dbp5-mantADP·BeF3 complex was
formed by mixing concentrated Δ90Dbp5 in solution with
a 1.2:1 molar ratio of rU10 RNA (IDT), incubating 15 min,
and then mixing mantADP·BeF3 (prepared in a 1:3:15
ratio of ADP:Be:F) to a final concentration of 1 mM,
followed by another 15 min of incubation. Crystallization of
Δ90Dbp5-mantADP·BeF3 was performed by hanging-drop
vapor diffusion at 18 °Cbymixing 100 nLof the complexat a
protein concentration of 16 mg mL−1 with 100 nL of
reservoir solution containing 200 mM Mg(NO3)2 and 18%
polyethyleneglycol 3350and incubating 4 daysover 100 μL
of reservoir solution in a sealed chamber. Crystals were
transferred to a cryoprotectant solution containing 18%
polyethylene glycol 3350, 9 mM Hepes(pH 7.5),
180 mM Mg(NO3)2, 4.5% glycerol, 1 mM DTT, 90 mM
NaCl, 0.25 mM InsP6, 4.5 mM MgCl2, and 1 mM
mantADP·BeF3 (prepared in a 1:3:15 ration of ADP:Be:F)
and were flash frozen in liquid nitrogen.
Crystallographicdatacollection,structuredetermination,
and refinement
Data were collected at 100 K on the NECAT 24-ID-E
beam line of the Advanced Photon Source at the Argonne
National Laboratory and processed with HKL [83]. Crystals
belonged to the space group P212121. The structure of
Δ90Dbp5-mantADP·BeF3 was determined by molecular
replacement with Phaser using the entire Dbp5 subunit
(PDB ID 3PEY) as a search model [84]. The atomic
coordinates and temperature factors were refined with
REFMAC5, initially with noncrystallographic symmetry
restraints applied [85]. The atomic model was improved
with cycles of model building with Coot [86] followed by
positional refinement. Rigid-body motions were modeled
with REFMAC5 in terms of TLS tensors for translation,
libration, and screw rotation [87]. Water molecules were
added using an automated procedure in Coot and by
visual inspection. A final round of refinement was
performed with PHENIX [88]. Atomic coordinates and
structure factors have been deposited in the Protein Data
Bank under accession code 5ELX. See Table S2 for data
collection and refinement statistics.
Steady-state ATPase assays
Time courses of Dbp5 (0.6–1 μM) steady-state ATPase
assayed by absorbance change at 340 nm using the
NADH-coupled assay were acquired on a Perkin-Elmer
Lambda 20 UV–Vis spectrophotometer thermostatted at
25 °C [13,43,66]. The [ATP] dependence of the initial
steady-state ATPase rate (v0) was fitted to the Michaelis–
Menten equation:
v0 ¼ k cat H½ T T½ T½  þ KM;ATP ð10Þ
where kcat is the maximal turnover rate of Dbp5 at
saturating ATP in units of s−1, [H]T is the total Dbp5
concentration, KM,ATP is the Michaelis constant for ATP,
and [T] is the total [ATP]. The [ADP] under our conditions of
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were also performed using ATPγS as a substrate.
RNA-stimulated steady-state ATPase experiments were
performed as detailed above, using 100 nM Dbp5 and
20 mM ATP. Data were fitted to the quadratic form of the
Briggs–Haldane equation
vobs ¼ kcat−k0ð Þ
H½ T þ R½ T þ KM ;RNA−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
H½ T þ R½ T þ KM;RNA
 2−4 H½ T R½ T
q
2 H½ T
þ k0
ð11Þ
where [R]T is the total RNA concentration in nucleotides
[14,66].
Transient kinetic assays
Transient kinetic measurements were performed with an
Applied Photophysics SX2.0 stopped-flow apparatus
thermostatted at 25 ± 0.1 °C [13–15,30,66]. The time
courses shown are either of raw, unaveraged traces or
the average of 2–3 traces. The concentrations stated are
final after mixing. Uncertainties are reported as standard
errors in the fits unless stated otherwise. The following
minimal reaction scheme with corresponding fundamental
rate (k) and equilibrium constants (K, defined by ratio of
corresponding k values) was used for analysis and
modeling[13–15,66]:(Scheme 1)
ðScheme1Þ
where H is Dbp5, T is ATP, D is ADP, and Pi is inorganic
phosphate. We assume that product release is sequential
with Pi preceding ADP. Several processes (e.g., nucleo-
tide binding) are likely to be associated with multiple
transitions (e.g., binding followed by an isomerization of
the Dbp5 nucleotide complex) but are omitted for simplicity
[8,13–15,66].
Nucleotide binding
Time courses of mant-nucleotide binding were mea-
sured by FRET from Dbp5 tryptophans to bound nucleo-
tides. Fluorescence (λex = 280 nm) was monitored
through a 400-nm-long pass colored filter. Inner filter
effects from mant-nucleotide absorption are minimal at the
mant-nucleotide concentrations used (b120 μM). Time
courses of association were acquired under both pseu-
do-first-order and nonpseudo-first-order conditions. Data
acquired under pseudo-first-order conditions were fitted to
a linear sum of exponentials. Time courses acquired under
nonpseudo-first-order conditions were fitted with the
following expression[89]:
F 0 þ A0 1− r−1re−k0 t−1 e
−k0 t
 
þ
Xn
i¼1
Ai 1−e−ki t
  ð12Þ
where F0 is the signal at time (t ) = 0, A0 and k0 are the
signal amplitude and observed rate constant of the first
phase, and r is an indication of the deviation of the
bimolecular binding term [the second term in Eq. (12)] from
a single exponential. Under pseudo-first-order conditions, rapproaches 0 and the second term collapses to an
exponential. When pseudo-first-order conditions are not
observed, r approaches 1, creating significant deviations
from a single exponential [89]. The terms Ai and ki (i =
1,…, n) are the amplitudes and observed rate constants of
additional phases following bimolecular binding, respec-
tively. Irreversible mantADP dissociation was measured
by rapidly mixing a pre-equilibrated mixture of 1 μM Dbp5
and 10 μMmantADPwith 1 mMADP and the time courses
of fluorescence change were fitted to a sum of exponen-
tials [51,66].
Unlabeled nucleotide binding was measured by kinetic
competition with mant-labeled nucleotides [35,51]. Time
courses of fluorescence change associated with mant-nu-
cleotide binding after rapidly mixing 0.5–0.6 μM Dbp5 with
a mixture of 20 or 50 μMmant nucleotide (either mantADP
or mantATP) and varying concentrations of unlabeled
nucleotide (ATP or ADP) were fitted to a sum of
exponentials. The unlabeled nucleotide binding affinity
(dissociation equilibrium constant, Kd) was determined
from the [unlabeled nucleotide] dependence of the
observed mant-nucleotide binding rate constant, as
defined by [51,64]:
kobs ¼ k0−k∞ð Þ
1þ N½ 
K d
þ k∞ ð13Þ
where [N] is unlabeled nucleotide concentration and k0 is the
observed mant-nucleotide rate constant in the absence of
competing unlabeled nucleotide ([N] = 0), and k∞ at saturat-
ing [N].
Transient Pi release of intrinsic Dbp5 ATPase
Phosphate release from Dbp5 was assayed from the
eightfold increase in fluorescence (λex = 436 nm,
463-nm-long pass colored glass emission filter) of the
iMDCC-labeled PiBiP upon binding phosphate. Contami-
nating Pi was removed from all equipment and buffers with
a Pi “mop” consisting of 0.5 mM 7-methylguanosine and
0.01 U/mL purine nucleoside phosphorylase (Sigma).
Since the process of mop's scavenging free Pi in solution
is very slow on the seconds timescale and PiBiP binds Pi
much faster (b100 ms) and extremely tightly, the presence
of mop has minimal effect on transient and steady-state Pi
release measurements, especially at short timescales [62].
Furthermore, 7-methylguanosine (up to 250 μM) does not
alter mantATP binding kinetics (data not shown). PiBiP
fluorescence was converted into [Pi] following calibration
with phosphate standard solutions. Time courses of Pi
liberation ([Pi]) measured after rapidly mixing 0.5 μM
Dbp5 with an equilibrated mixture of 5 μM PiBiP and
varying ATP concentrations were fitted to the following
expression defining a lag phase followed by a linear
phase[13,14]:
Pi½  ¼ β 1λ e
−λt−1
 þ t
 
þ Pi;0 ð14Þ
The linear regime represents steady-state ATPase, and
its slope (given by β) is the turnover rate. The lag phase is
defined by an exponential with observed rate constant λ.
The [ATP] dependence of the observed lag phase rate
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form[13,14]:
λ ¼ λ∞−λ0ð Þ T½ 
K T þ T½  þ λ0 ð15Þ
where [T] is the ATP concentration, λ∞ is the observed lag
phase rate constant at saturating ATP, λ0 is the intercept
value at zero ATP, and KT is the ATP dissociation
equilibrium constant.
RNA-stimulated transient Pi release of Dbp5 ATPase
Single-mix experiments were conducted above with the
following modifications: 0.4 μM Dbp5 was pre-equilibrated
with varying concentrations of RNA and was rapidly mixed
with 2.5 mM ATP pre-equilibrated with 5 μM PiBiP. Pi mop
was present in all solutions. Data were analyzed as
detailed above.
Dual-mix experiments were conducted as above, with
the modification that all solutions contained both 5 μM
PiBiP and Pi mop. Using the dual-mix mode of the SX20
stopped flow, we mixed 5 μM Dbp5 with 4 mM ATP and
aged it for 0.05, 6, or 25 s. After aging, we rapidly mixed
the Dbp5/ATP solution with 0 or 10 mM RNA (nucleotide).
Final concentrations were 2.5 μM Dbp5, 2 mM ATP, 0 or
10 mM RNA, and 5 μM PiBiP. Time courses of [Pi] release
in the absence of RNA were fit to a sum of bimolecular
binding and a linear function. Time courses of [Pi] in the
presence of RNA were fit to the following sum of
bimolecular binding and combined lag/linear phase:
½Pi ¼ F 0 þ A0 1− r−1re−k0t−1e
−k0t
 
þ β 1
λ
e−λt−1
 þ t
 
ð16Þ
Oxygen isotope exchange
ATPase reactions (5–10 μM Dbp5 and 5–10 mM ATP)
were conducted in 5–6 mM phosphoenolpyruvate,
50 U mL−1 phosphoenolpyruvate kinase, and 48.5%
18O-labeled water. Reactions were run at room tempera-
ture for several hours to generate 2–3 mM Pi, then
quenched with an equivalent volume of 1 N HCl. Pi was
isolated and analyzed by coupled gas chromatography/
mass spectrometry (GCMS) [61,64]. GCMS analysis of Pi
samples from hydrolysis of unlabeled ATP in 18O-enriched
water yields the distribution of species with zero to four 18O
oxygens per Pi. The Pc value was not determined by global
fitting of this complete distribution because the starting
reactions contained variable amounts of unenriched Pi that
result in an excess of the 18O0 species. At the low extents
of reversal observed with Dbp5, most of the Pi contains
only one water-derived oxygen with only a small amount of
Pi that contains two water-derived oxygens. The amount of
the species with two water-derived oxygens increases with
increasing Pc value. The ratio of the
18O2:
18O1 species
with 2 versus 1 labeled oxygens was therefore used to
determine Pc because this ratio only depends on the
enrichment in the water and the Pc value and isuninfluenced by the amount of contaminating unenriched
Pi.
Oxygen isotope exchange experiments were also
performed with RNA-stimulated Dbp5 ATPase activity.
Steady-state reactions in the presence of RNA used 2 μM
Dbp5, 2.5 mM ATP, and 8 mM polyU RNA. Data were
analyzed as above.
Simulation of transient and steady-state activity
Kinetic simulations by global fitting of both steady-state
ATPase time courses acquired with the NADH assay and
transient/steady-state Pi release acquired by PiBiP fluo-
rescence were performed using Scheme 1 and KinTek
Global Kinetic Explorer Software (KinTek Corp.) [90,91]. A
rapid (≫kcat; e.g., ≥10 s−1) transition accounting for ATP
regeneration from liberated ADP was also included to
account for the activity of lactate dehydrogenase and
phosphoenolpyruvate kinase in the NADH assay.
Accession numbers
Coordinates of the crystal structure of Dbp5 bound
to RNA and mantADP·BeF3 have been deposited in
the Protein Data Bank under the accession number
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